e144
     
     
 
OMB APPROVAL
 
 
OMB Number: 3235-0101
Expires: December 31, 2009
Estimated average burden hours per response......... 2.00
 
 
SEC USE ONLY
 
 
DOCUMENT SEQUENCE NO.



 
 
CUSIP NUMBER



 
 
WORK LOCATION



 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 144

NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

     
ATTENTION:   Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker.
                                             
       
1 (a) NAME OF ISSUER (Please type or print)                (b) IRS IDENT. NO.    (c) S.E.C. FILE NO.            
 
                                           
Natural Health Trends Corp.            59-2705336    0-26272              
 
                                           
     
1 (d) ADDRESS OF ISSUER
STREET           CITY   STATE   ZIP CODE    (e) TELEPHONE NO.  
             AREA CODE    NUMBER    
 
                                           
 
      2050 Diplomat Drive           Dallas   Texas   75234      972    241-4080
   
2 (a) NAME OF PERSON FOR WHOSE ACCOUNT THE SECURITIES ARE TO BE SOLD
       (b) IRS IDENT. NO.    (c) RELATIONSHIP
     TO ISSUER
       (d) ADDRESS STREET   CITY   STATE   ZIP CODE
 
                                           
Gary C. Wallace
           N/A    Officer        2050 Diplomat Drive   Dallas   Texas     75234  
 
INSTRUCTION : The person filing this notice should contact the issuer to obtain the I.R.S. Identification Number and the S.E.C. File Number.
                                                           
                                               
  3 (a)     (b)         SEC USE ONLY     (c)     (d)     (e)     (f)     (g)  
  Title of the         Name and Address of Each Broker Through Whom the     Broker-Dealer     Number of Shares     Aggregate     Number of Shares     Approximate     Name of Each  
  Class of         Securities are to be Offered or Each Market Maker     File Number     or Other Units     Market     or Other Units     Date of Sale     Securities  
  Securities         who is Acquiring the Securities           To Be Sold     Value     Outstanding     (See instr. 3(f))     Exchange  
  To Be Sold                     (See instr. 3(c))     (See instr. 3(d))     (See instr. 3(e))     (MO. DAY YR.)     (See instr. 3(g))  
 
 
                                                       
                                               
 
Common Stock
        E*Trade             583       $ 204.13       *******     12/16/08     Nasdaq Capital  
 
 
        671 N. Glebe Road, 11th Floor                     (per12/15/08                 Market  
 
 
        Arlington, Virginia 22203                     closing price)                    
                                               
 
Common Stock
        E*Trade             140       $ 49.00       ********     12/16/08     Nasdaq Capital  
 
 
        671 N. Glebe Road, 11th Floor                     (per 12/15/08                 Market  
 
 
        Arlington, Virginia 22203                     closing price)                    
                                               
 
Common Stock
        E*Trade             467       $ 583.45       ********     12/16/08     Nasdaq Capital  
 
 
        671 N. Glebe Road, 11th Floor                     (per 12/15/08                 Market  
 
 
        Arlington, Virginia 22203                     closing price)                    
                                               
 
Common Stock
        E*Trade             117       $ 40.87       ********     12/16/08     Nasdaq Capital  
 
 
        671 N. Glebe Road, 11th Floor                     (per 12/15/08                 Market  
 
 
        Arlington, Virginia 22203                     closing price)                    
                                               
 
Common Stock
        E*Trade             1202       $ 877.98       ********     12/16/08     Nasdaq Capital  
 
 
        671 N. Glebe Road, 11th Floor                     (per 12/15/08                 Market  
 
 
        Arlington, Virginia 22203                     closing price)                    
                                               
INSTRUCTIONS:
                         
1.
  (a)   Name of issuer     3.     (a)   Title of the class of securities to be sold
 
  (b)   Issuer’s I.R.S. Identification Number           (b)   Name and address of each broker through whom the securities are intended to be sold
 
  (c)   Issuer’s S.E.C. file number, if any           (c)   Number of shares or other units to be sold (if debt securities, give the aggregate face amount)
 
  (d)   Issuer’s address, including zip code           (d)   Aggregate market value of the securities to be sold as of a specified date within 10 days prior to the filing of this notice
 
  (e)   Issuer’s telephone number, including area code           (e)   Number of shares or other units of the class outstanding, or if debt securities the face amount thereof outstanding, as shown by the most recent report or statement published by the issuer
 
                  (f)   Approximate date on which the securities are to be sold
 
                  (g)   Name of each securities exchange, if any, on which the securities are intended to be sold
2.
  (a)   Name of person for whose account the securities are to be sold                
 
  (b)   Such person’s I.R.S. identification number, if such person is an entity                
 
  (c)   Such person’s relationship to the issuer (e.g., officer, director, 10% stockholder, or member of immediate family of any of the foregoing)                
 
  (d)   Such person’s address, including zip code                
Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB control number.


 

TABLE I — SECURITIES TO BE SOLD
Furnish the following information with respect to the acquisition of the securities to be sold
and with respect to the payment of all or any of the purchase price or other consideration therefor:
                                             
 
  Title of     Date you           Name of Person from Whom Acquired     Amount of     Date of        
  the Class     Acquired     Nature of Acquisition Transaction     (If gift, also give date donor acquired)     Securities Acquired     Payment     Nature of Payment  
 
Common Stock
    April 21, 2007     Grant of Restricted Stock     Natural Health Trends Corp.       25,000       N/A     N/A  
 
 
                                         
 
Common Stock
    June 26, 2007     Grant of Restricted Stock     Natural Health Trends Corp.       6,000       N/A     N/A  
 
 
                                         
 
Common Stock
    Dec. 31, 2007     Grant of Restricted Stock     Natural Health Trends Corp.       5,000       N/A     N/A  
 
 
                                         
 
Common Stock
    March 15, 2008     Grant of Restricted Stock     Natural Health Trends Corp.       20,000       N/A     N/A  
 
 
                                         
 
Common Stock
    Nov. 13, 2008     Grant of Restricted Stock     Natural Health Trends Corp.       51,500       N/A     N/A  
 
         
INSTRUCTIONS:
 
If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.
   
 
TABLE II — SECURITIES SOLD DURING THE PAST 3 MONTHS
Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.
                                             
 
                            Amount of            
  Name and Address of Seller     Title of Securities Sold       Date of Sale       Securities Acquired       Gross Proceeds    
 
 
                                         
 
 
                                         
 
 
                                         
 
 
                                         
 
     
REMARKS:
  The shares covered by this Form 144 are being sold pursuant to Rule 10b5-1(c) sales plans dated June 15, 2007, September 12, 2007, June 6, 2008, and December 15, 2008, respectively, and the representation below regarding the seller’s knowledge of material information speaks as of that plan adoption dates for the sales covered by those plans. The proceeds derived from the sale of shares covered by this Form 144 will be applied to the payment of taxes resulting from the vesting of certain of the above referenced shares of restricted stock. The exact number of shares to be sold as indicated in Item 3(c) above is subject to the actual price per share at which shares are sold to generate the proceeds required to pay taxes.
       
 
INSTRUCTIONS:
  ATTENTION:
See the definition of “person” in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
 
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed.
 
         
  December 16, 2008             /s/ Gary C. Wallace  
         
  DATE OF NOTICE   (SIGNATURE)  
The notice shall be signed by the person for whose account the securities are to be sold. At least one copy of the notice shall be manually signed.
Any copies not manually signed shall bear typed or printed signatures.

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)